Track record
Michael Seth Altman
An officer, director or large holder of 7 blank-check companies. Every role below was declared by Michael Seth Altman in an SEC ownership filing.
Vehicles
7
Still live
0
Closed a deal
6 of 7
Capital involved
$723M
Every vehicle, newest first
- Adagio Medical Holdings, Inc.ADGM · 10% holder · IPO Aug 1, 2024Completed
- Freenome, Inc.FRNM · Chief Business Officer · IPO Jun 12, 2024$85.1MCompleted
- ARYA Sciences Acquisition Corp V— · Chief Financial Officer · IPO Jul 14, 2021$153MLiquidated
- ARYA Sciences Acquisition Corp IV— · Chief Financial Officer · IPO Mar 1, 2021$37.1MCompleted
- Nautilus Biotechnology, Inc.NAUT · Chief Financial Officer · IPO Aug 10, 2020$150MCompleted
- Cerevel Therapeutics Holdings, Inc.— · Chief Financial Officer · IPO Jun 8, 2020$150MCompleted
- ARYA SCIENCES ACQUISITION CORP.— · Chief Financial Officer · IPO Oct 9, 2018$149MCompleted
Compiled from Forms 3 and 3/A filed with the SEC under CIK 1746738. Roles are as declared at the time of filing and may have changed since. Nothing here is a judgement about any individual.